Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and Bupivacaine Caudal Block in Pediatric Hernia Repair
NCT06668220Phase 1Not yet recruiting
- Sponsor
- Assiut University
- Start
- Nov 2024
- Primary completion
- Oct 2026
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, single-blind trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Assiut University. Primary endpoint: Duration of analgesia at 24 hours. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06668220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06668220.